PortfoliosLab logoPortfoliosLab logo
BYRN vs. ZIVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BYRN vs. ZIVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Byrna Technologies Inc. (BYRN) and ZIVO Bioscience, Inc. (ZIVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BYRN achieves a -62.18% return, which is significantly lower than ZIVO's -57.82% return. Over the past 10 years, BYRN has underperformed ZIVO with an annualized return of 10.22%, while ZIVO has yielded a comparatively higher 25.93% annualized return.


BYRN

1D
-1.55%
1M
27.00%
YTD
-62.18%
6M
-66.08%
1Y
-79.89%
3Y*
7.86%
5Y*
-23.39%
10Y*
10.22%

ZIVO

1D
8.68%
1M
35.93%
YTD
-57.82%
6M
-47.27%
1Y
-73.77%
3Y*
-39.34%
5Y*
-33.49%
10Y*
25.93%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BYRN vs. ZIVO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BYRN
Byrna Technologies Inc.
-62.18%-41.72%350.86%-18.49%-41.27%-7.93%663.16%26.67%7.14%-30.00%
ZIVO
ZIVO Bioscience, Inc.
-57.82%-59.53%1,691.67%-92.00%-12.89%1,813.33%-11.76%30.77%44.44%-5.26%

Correlation

The correlation between BYRN and ZIVO is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.06

Correlation (5Y)
Calculated over the trailing 5-year period

0.07

Correlation (10Y)
Calculated over the trailing 10-year period

0.05

Correlation (All Time)
Calculated using the full available price history since Sep 24, 2012

0.03

The correlation between BYRN and ZIVO shifts across timeframes, from 0.03 (all time) to 0.14 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

BYRN:

$151.32M

ZIVO:

$14.26M

EPS

BYRN:

$0.37

ZIVO:

-$2.58

PS Ratio

BYRN:

1.26

ZIVO:

118.32

Total Revenue (TTM)

BYRN:

$120.98M

ZIVO:

$119.03K

Gross Profit (TTM)

BYRN:

$72.95M

ZIVO:

$39.21K

EBITDA (TTM)

BYRN:

$12.75M

ZIVO:

-$9.86M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BYRN vs. ZIVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BYRN
BYRN Risk / Return Rank: 44
Overall Rank
BYRN Sharpe Ratio Rank: 44
Sharpe Ratio Rank
BYRN Sortino Ratio Rank: 22
Sortino Ratio Rank
BYRN Omega Ratio Rank: 22
Omega Ratio Rank
BYRN Calmar Ratio Rank: 55
Calmar Ratio Rank
BYRN Martin Ratio Rank: 88
Martin Ratio Rank

ZIVO
ZIVO Risk / Return Rank: 2222
Overall Rank
ZIVO Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
ZIVO Sortino Ratio Rank: 3434
Sortino Ratio Rank
ZIVO Omega Ratio Rank: 3434
Omega Ratio Rank
ZIVO Calmar Ratio Rank: 1313
Calmar Ratio Rank
ZIVO Martin Ratio Rank: 77
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BYRN vs. ZIVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Byrna Technologies Inc. (BYRN) and ZIVO Bioscience, Inc. (ZIVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BYRNZIVODifference
Sharpe ratioReturn per unit of total volatility

-0.66

Sortino ratioReturn per unit of downside risk

-2.34

Omega ratioGain probability vs. loss probability

0.72

1.01

-0.30

Calmar ratioReturn relative to maximum drawdown

-0.94

-0.79

-0.15

Martin ratioReturn relative to average drawdown

-1.45

-1.45

0.00

BYRN vs. ZIVO - Sharpe Ratio Comparison

The current BYRN Sharpe Ratio is -1.08, which is lower than the ZIVO Sharpe Ratio of -0.42. The chart below compares the historical Sharpe Ratios of BYRN and ZIVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BYRN vs. ZIVO - Drawdown Comparison

The maximum BYRN drawdown since its inception was -92.51%, smaller than the maximum ZIVO drawdown of -98.52%. Use the drawdown chart below to compare losses from any high point for BYRN and ZIVO.


Loading charts...

Drawdown Indicators


BYRNZIVODifference

Max Drawdown

Largest peak-to-trough decline

-92.51%

-98.52%

+6.01%

Max Drawdown (1Y)

Largest decline over 1 year

-85.22%

-93.85%

+8.63%

Max Drawdown (3Y)

Largest decline over 3 years

-85.49%

-97.16%

+11.67%

Max Drawdown (5Y)

Largest decline over 5 years

-92.51%

-98.52%

+6.01%

Max Drawdown (10Y)

Largest decline over 10 years

-92.51%

-98.52%

+6.01%

Current Drawdown

Current decline from peak

-81.43%

-88.78%

+7.35%

Average Drawdown

Average peak-to-trough decline

-52.36%

-63.76%

+11.40%

Ulcer Index

Depth and duration of drawdowns from previous peaks

55.16%

50.79%

+4.37%

Volatility

BYRN vs. ZIVO - Volatility Comparison

The current volatility for Byrna Technologies Inc. (BYRN) is 17.02%, while ZIVO Bioscience, Inc. (ZIVO) has a volatility of 46.88%. This indicates that BYRN experiences smaller price fluctuations and is considered to be less risky than ZIVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BYRNZIVODifference

Volatility (1M)

Calculated over the trailing 1-month period

17.02%

46.88%

-29.86%

Volatility (6M)

Calculated over the trailing 6-month period

59.78%

144.75%

-84.97%

Volatility (1Y)

Calculated over the trailing 1-year period

74.16%

173.95%

-99.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

73.23%

139.12%

-65.89%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

95.32%

1,082.32%

-987.00%

Dividends

BYRN vs. ZIVO - Dividend Comparison

Neither BYRN nor ZIVO has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

BYRN vs. ZIVO - Financials Comparison

This section allows you to compare key financial metrics between Byrna Technologies Inc. and ZIVO Bioscience, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
29.05M
0
(BYRN) Total Revenue
(ZIVO) Total Revenue
Values in USD except per share items

Frequently Asked Questions


BYRN and ZIVO have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ZIVO has higher volatility (46.88%) compared to BYRN (17.02%). In terms of maximum drawdown, BYRN dropped -92.51% vs ZIVO's -98.52%.

ZIVO currently has the higher Sharpe Ratio (-0.42 vs -1.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BYRN and ZIVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer